0000000000292375

AUTHOR

Gerhard Weisser

showing 6 related works from this author

Tissue optical perfusion pressure: a simplified, more reliable, and faster assessment of pedal microcirculation in peripheral artery disease

2020

Oscillometry is an alternative to continuous-wave Doppler (cw-Doppler) to determine peripheral artery disease (PAD) severity using the ankle-brachial index (ABI). cw-Doppler ABI differentiates systolic pressure of ATP and ADP where either one of both values in most patients is higher (high) and the other value is lower (low). In contrast, oscillometric ABI measures the strongest signal and hence misses the lower value. Both do not take pedal perfusion into consideration. Simultaneous determination of tissue microperfusion cares for pedal PAD. ABI was determined by cw-Doppler and oscillometry. Tissue optical perfusion pressure (TOPP) was taken from the first toe using photoplethysmography. 3…

Malemedicine.medical_specialtyPhysiologyArterial diseaseBlood Pressure030204 cardiovascular system & hematologyWorkflowMicrocirculationPeripheral Arterial Disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsOscillometryPhysiology (medical)Internal medicinePhotoplethysmogramHumansMedicineAnkle Brachial Index030212 general & internal medicinePhotoplethysmographyAgedRetrospective StudiesAged 80 and overFootbusiness.industryMicrocirculationReproducibility of ResultsUltrasonography DopplerMiddle Agedbody regionsRegional Blood FlowCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPerfusionAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Predictors of new-onset peripheral artery disease Comment on Krause et al., p. 403 - 410.

2016

medicine.medical_specialtyPeripheral Arterial DiseaseText miningbusiness.industryArterial diseaseInternal medicinemedicineCardiologyHumansDiseaseCardiology and Cardiovascular MedicinebusinessNew onsetVASA. Zeitschrift fur Gefasskrankheiten
researchProduct

β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension

2011

The use of β-receptor blockers in peripheral arterial disease is controversial for their impact on vasomotor tone. The β-blocker nebivolol possesses vasodilating, endothelium-dependent, NO-releasing properties that might be beneficial in peripheral arterial disease. The aim of the study was to evaluate the effects and tolerability of nebivolol in comparison with metoprolol in these patients. A total of 128 patients with intermittent claudication and essential hypertension were included and double-blind randomized to receive 5 mg of nebivolol (N=65) or 95 mg of metoprolol (N=63) once daily. End points were changes in ankle-brachial index, initial and absolute claudication distance, endothel…

Malemedicine.medical_specialtyBrachial ArteryAdrenergic beta-AntagonistsArterial Occlusive DiseasesBlood PressureEssential hypertensionNebivololDouble-Blind MethodSurveys and QuestionnairesInternal medicinemedicine.arteryInternal MedicinemedicineHumansAnkle Brachial IndexBenzopyransBrachial arteryAntihypertensive AgentsMetoprololbusiness.industryIntermittent Claudicationmedicine.diseaseNebivololIntermittent claudicationTreatment OutcomeBlood pressureTolerabilityEthanolaminesAnesthesiaHypertensionQuality of LifeCardiologyFemalemedicine.symptomClaudicationbusinessMetoprololmedicine.drugHypertension
researchProduct

Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position

2020

Abstract Objective The objective of this study was to analyze the outcome of a contemporary series of femoropopliteal bypass operations with the glutaraldehyde denatured polyester mesh-reinforced ovine collagen prosthesis (OCP; Omniflow II [LeMaitre Vascular, Inc, Burlington, Mass]). The experience of two tertiary centers regarding long-term graft function, secondary reinterventions, and biodegeneration of the OCP prosthesis is presented. Methods Between January 2006 and January 2014, a series of 205 consecutive operations with the OCP in the femoropopliteal position (54 above knee and 151 below knee) were performed in 194 patients in 202 limbs for disabling claudication (72), chronic criti…

MaleReoperationmedicine.medical_specialtyPolyestersmedicine.medical_treatmentIschemia030204 cardiovascular system & hematologyProsthesisBlood Vessel Prosthesis Implantation03 medical and health sciencesPostoperative Complications0302 clinical medicineAneurysmBlood vessel prosthesisOcclusionmedicineAnimalsHumansVascular PatencyPopliteal Artery030212 general & internal medicineSheep DomesticVascular PatencyAgedRetrospective StudiesAged 80 and overBioprosthesisPeripheral Vascular Diseasesmedicine.diagnostic_testbusiness.industryAngiographyMiddle AgedSurgical MeshLimb Salvagemedicine.diseaseBlood Vessel ProsthesisSurgeryFemoral ArteryGlutaralAngiographyFemaleSurgeryCollagenmedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessJournal of Vascular Surgery
researchProduct

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants

2020

AbstractAs a result of the successful completion of their respective phase III studies compared with vitamin K antagonists (VKAs), four direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism (VTE). These DOACs—apixaban, dabigatran, edoxaban, and rivaroxaban—have subsequently seen a steady uptake among clinicians since their approval. Despite the suitability of DOACs for a broad range of patients, they are not appropriate in certain situations, whereas in others they require additional considerations such as dose reductions. Subanalyses of phase III trials and studies on specific VTE patient populations have been conducted t…

Male0301 basic medicineComorbidity030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicinePregnancyEdoxabanNeoplasmsSecondary PreventionChildspecial populationsAge FactorsVenous ThromboembolismHematologyMiddle AgedTreatment OutcomePractice Guidelines as TopicFemaleKidney Diseasesmedicine.drugAdultmedicine.medical_specialtyMEDLINEHemorrhagecomorbiditiesdirect oral anticoagulantsDabigatran03 medical and health sciencesmedicineHumansLactationDosingIntensive care medicineAgedDose-Response Relationship Drugbusiness.industryPatient SelectionPregnancy Complications HematologicContraindications DrugAnticoagulantsmedicine.diseaseComorbidityReview articleClinical trial030104 developmental biologyClinical Trials Phase III as TopicchemistrybusinessVenous thromboembolismFactor Xa InhibitorsThrombosis and Haemostasis
researchProduct

Reentry devices for chronic arterial occlusions.

2019

Iliac arterymedicine.medical_specialtybusiness.industryTreatment outcomeMEDLINEArterial Occlusive DiseasesReentryIliac ArteryChronic diseaseText miningTreatment OutcomeArterial occlusionsInternal medicineArterial Occlusive DiseasesChronic DiseaseCardiologyMedicineHumansCardiology and Cardiovascular MedicinebusinessVASA. Zeitschrift fur Gefasskrankheiten
researchProduct